• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF; OXYGENTOR Back to Search Results
Catalog Number CX*FX25RW
Device Problem Power Problem (3010)
Patient Problems No Patient Involvement (2645); No Information (3190)
Event Date 08/14/2015
Event Type  malfunction  
Manufacturer Narrative
The actual device has been returned to the manufacturing facility and the investigation is currently ongoing.A follow up will be sent within 30 days of this report being sent.A review of the device history record and the product release decision control sheet confirmed that there is no indication of production-related problem or of discrepancy in the test/inspection results.A search of the complaint file found no other report of this nature with the involved product/lot# combination.(b)(4).All available information has been placed on file in quality assurance for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported that the capiox fx25 oxygenator shut down.Additional details have been requested.
 
Manufacturer Narrative
This report is being submitted as follow-up no.1 for mfg.Report no.9681834-2015-00195 to provide the return sample evaluation results as well as to update sections report type, type of reportable event.Follow up communication with the user facility confirmed that there was no patient involvement.With no patient involvement the report type is no longer classified as adverse and has been updated to reflect a product problem.Considered a malfunction, (b)(4).The actual device was returned to the manufacturing facility for evaluation.Visual inspection upon receipt did not find any obvious anomalies in the appearance.The actual sample was rinsed and dried and subjected to another visual inspection.No anomaly in the appearance was revealed.The actual sample was built into a circuit with tubes and bovine blood was circulated in it at each flow rate, while the pressure drop was determined and confirmed to meet manufacturing specifications.The actual sample was confirmed not to have any occlusion that may lead a pressure rise in the circuit.A review of the manufacturing record of the involved product /lot# combination confirmed that there were no indications of production-related problems.There were no nonconforming indications in the shipping inspection record of the involved product /lot# combination.A search of the complaint file did not find any other report with the involved product/lot# combination.The exact cause of the complaint cannot be determined based on the available information, however a potential cause of the reported blocking in the oxygenator could have been thrombus formation.The device labeling does address the potential for such an occurrence in the instruction for use (ifu) with the statement such as the following: "adequate heparinization of the blood is required to prevent it from clotting in the system.Do not reduce heparin during circulation, otherwise, blood clotting might occur." all available information has been placed on file in quality management for appropriate tracking, trending and follow up.(b)(4).
 
Event Description
This report is being submitted as follow-up no.1 for mfg.Report no.9681834-2015-00195 to provide the return sample evaluation results as well as to update report type, type of reportable event.Follow up communication with the user facility confirmed that there was no patient involvement.With no patient involvement the report type is no longer classified as adverse and has been updated to reflect a product problem in.Section now considered a malfunction, (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX25 HOLLOW FIBER OXYGENATOR AF
Type of Device
OXYGENTOR
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
kathleen little
reg. no. 2243441
2101 cottontail ln.
summerset, NJ 08873
8002837866
MDR Report Key5055814
MDR Text Key24988859
Report Number9681834-2015-00195
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Report Date 08/14/2015,09/04/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2018
Device Catalogue NumberCX*FX25RW
Device Lot Number150402
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2015
Is the Reporter a Health Professional? No
Distributor Facility Aware Date08/14/2015
Device Age5 MO
Event Location Hospital
Date Report to Manufacturer08/14/2015
Date Manufacturer Received08/31/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/02/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-